Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting.

Marko LukicMaria EleftheriadouRobin D HamiltonRanjan RajendramKajo BucanPraveen J Patel

Published in: European journal of ophthalmology (2020)

The results suggest that good long-term morphological and functional treatment outcomes can be achieved using intravitreal aflibercept for nAMD in a real-life clinical setting.

Keyphrases

age related macular degeneration
type diabetes
metabolic syndrome
adipose tissue
glycemic control